These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 53783)

  • 21. Immunochemical determination of human chorionic gonadotropin and alpha-fetoprotein in sera and tumors of patients with testicular cancer.
    Javadpour N; McIntire KR; Waldmann TA
    Natl Cancer Inst Monogr; 1978 Dec; (49):209-13. PubMed ID: 86162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Testis cancer markers. Clinical use].
    Salesi N; Di Cocco B; Alghisi F; Calabretta F; Bossone G
    Minerva Med; 2002 Oct; 93(5):365-9. PubMed ID: 12410169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)].
    Boewer C; Nawka S; Fleck H; Uibel M; Immer U; Schmidt HE; Herzmann H; Pilgrim G; Ziegenbein R
    Z Urol Nephrol; 1985 Feb; 78(2):77-86. PubMed ID: 2581393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience with serum alpha-fetoprotein and human chorionic gonadotropin in non-seminomatous testicular tumors.
    Fowler JE; Taylor G; Blom J; Stutzman RE
    J Urol; 1980 Sep; 124(3):365-8. PubMed ID: 6159485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The predictive value of pre-orchidectomy serum tumor markers in non seminomatous germ cell tumors of the testis (N.S.G.C.T.T.).
    Boccon-Gibod L; Le Doze H; Steg A
    Prog Clin Biol Res; 1985; 203():93-5. PubMed ID: 2421347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biological markers in cancer of the testis].
    Lotsberg J; Fosså SD; Klepp O; Orjasaeter H; Torjesen PA
    Tidsskr Nor Laegeforen; 1980 Apr; 100(12):688-90. PubMed ID: 6158120
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical significance of low level human chorionic gonadotropin in the management of testicular germ cell tumor.
    Takizawa A; Kishida T; Miura T; Hattori Y; Noguchi K; Kubota Y
    J Urol; 2008 Mar; 179(3):930-4; discussion 934-5. PubMed ID: 18207192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic value of tumour marker regression models in stage 1 marker-positive testicular cancer.
    May M; Helke C; Nitzke T; Seehafer M; Vogler H; Hoschke B
    Urol Int; 2004; 73(4):329-36. PubMed ID: 15604578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor markers in testicular cancer.
    Catalona WJ
    Urol Clin North Am; 1979 Oct; 6(3):613-28. PubMed ID: 92089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Biological markers and germinal tumors of the testis. Value and limitations of the assay of chorionic gonadotrophin hormone and alpha-fetoprotein].
    Bassoulet J; Pabot du Chatelard P; Ricordel I; Auberget JL; Guillemot MC; Merrer J; Timbal Y
    J Urol (Paris); 1988; 94(8):393-6. PubMed ID: 2467947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumour markers in testicular tumours.
    Chisholm GD
    Prog Clin Biol Res; 1985; 203():81-91. PubMed ID: 2421346
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biological markers in testicular cancer].
    Glait HM; Carugati A; Scorticati C; Koss A; Bellora O; Mickiewicz E; Arturi J; Olivari AJ
    Medicina (B Aires); 1982; 42(5):488-94. PubMed ID: 6188940
    [No Abstract]   [Full Text] [Related]  

  • 33. [Significance of measurement of serum levels of tumor markers with germinal cell testicular tumor--value of beta-subunit human chorionic gonadotropin and alpha-fetoprotein (author's transl)].
    Kamidono S; Arakawa S; Masuda M; Hamami G; Shimatani N; Itho N; Nakatsuka E; Fujii A; Ohono S; Ishigami J; Yoshimoto Y; Hattori M; Fujita T; Okada S
    Nihon Hinyokika Gakkai Zasshi; 1980 Apr; 71(4):352-62. PubMed ID: 6157042
    [No Abstract]   [Full Text] [Related]  

  • 34. Discordance of human chorionic gonadotropin and alpha-fetoprotein in testicular teratocarcinomas.
    Braunstein GD; McIntire KR; Waldmann TA
    Cancer; 1973 May; 31(5):1065-8. PubMed ID: 4122298
    [No Abstract]   [Full Text] [Related]  

  • 35. High-dose methotrexate, vincristine and cisplatin as salvage treatment for relapsed non-seminomatous germ-cell cancer.
    Sleijfer S; Van der Graaf WT; Willemse PH; De Vries EG; Schraffordt Koops H; Mulder NH
    Anticancer Res; 1995; 15(3):1039-42. PubMed ID: 7544087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of radioimmunoassay of human chorionic gonadotropin and alpha fetoprotein in nonseminomatous germ cell tumors of the testis.
    Kausitz J; Hupka S; Cerný V; Bohunický L; Korec S
    Neoplasma; 1980; 27(3):321-7. PubMed ID: 6161314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha-fetoprotein and HCG assays in testicular cancer.
    Javadpour N
    Urology; 1982 Sep; 20(3):350-1. PubMed ID: 6181605
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of alpha-fetoprotein and human chorionic gonadotropin in seminoma.
    Javadpour N; McIntire KR; Waldmann TA; Bergman SM
    J Urol; 1978 Dec; 120(6):687-90. PubMed ID: 83391
    [No Abstract]   [Full Text] [Related]  

  • 39. Serial monitoring of serum alpha-fetoprotein and chorionic gonadotropin in males with germ cell tumors.
    Thompson DK; Haddow JE
    Cancer; 1979 May; 43(5):1820-9. PubMed ID: 87255
    [No Abstract]   [Full Text] [Related]  

  • 40. Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
    Kausitz J; Ondrus D; Belan V; Matoska J
    Neoplasma; 1992; 39(6):357-61. PubMed ID: 1283444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.